Spruce Biosciences, Inc (SPRB) Price Prediction & ForecastSPRBSpruce Biosciences, Inc

Alphio's SPRB stock price prediction model matches the current Spruce Biosciences, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.25 (+0.78%). The 1-week path is $61.97 (+1.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Spruce Biosciences Inc is a good buy right now due to its recent price movement and positive clinical developments. The current price is $60.78, which is significantly below the analyst price target of $144 from Citizens, indicating a potential upside of 137%. Additionally, the stock has shown a strong 5-day change of +17.84% and a remarkable 1-year change of +520.20%, reflecting positive momentum. However, investors should be cautious of the negative earnings report with an EPS of -6.68, which missed estimates by 39.46%, indicating ongoing profitability challenges.

Spruce Biosciences, Inc (SPRB) last closed at $60.78, losing -3.98%. These facts feed the 1-day and 1-week SPRB price prediction above.